Abdiel Capital Advisors’s GoodRx Holdings GDRX Stock Holding History

Abdiel Capital Advisors’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,062,788	Closed	-$263M	–	10
2021 Q4	$263M	Buy	+8,062,788	New	+$324M	8.07%	7

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $903M AUM 113.12% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $795M AUM 5.23% 1-Year Est. Return

DIG

Dragoneer Investment Group San Francisco, California $2.83B AUM 12.55% 1-Year Est. Return

RRCP

Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $3.14B AUM 46.44% 1-Year Est. Return

Abdiel Capital Advisors's GDRX Position: Q1 2022 in Review

Abdiel Capital Advisors sold out of GoodRx Holdings (GDRX) in Q1 2022, closing a stake of 8,062,788 shares — an estimated $263M sold.

Abdiel Capital Advisors first reported a position in GDRX in Q4 2021 and held it in 1 quarter. The position peaked at $263M in Q4 2021. 167 funds tracked by Wall St. Rank hold GDRX as of Q1 2022.

Abdiel Capital Advisors reported no remaining GoodRx Holdings position as of Q1 2022 after selling out during the quarter.
Abdiel Capital Advisors sold 8,062,788 GoodRx Holdings shares in Q1 2022, an estimated $263M.
Abdiel Capital Advisors first reported a position in GoodRx Holdings in Q4 2021 and held it in 1 quarter.
Abdiel Capital Advisors's GoodRx Holdings position peaked at $263M in Q4 2021.
167 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2022.

Based on Abdiel Capital Advisors's 13F filing for Q1 2022, filed 16 May 2022.